DRGLIM-M2 Tablet | Glimepiride 2 mg & Metformin Hydrochloride Prolonged Release Tablets IP

DRGLIM-M2 Tablet is a combination anti-diabetic medicine used for the management of Type 2 Diabetes Mellitus in adults. It contains Glimepiride 2 mg and Metformin Hydrochloride Prolonged Release, which work together to control blood sugar levels effectively throughout the day.

Glimepiride stimulates the pancreas to release insulin, helping lower blood glucose levels, while Metformin Hydrochloride Prolonged Release improves insulin sensitivity and reduces glucose production in the liver. The prolonged-release formulation ensures steady glucose control with fewer gastrointestinal side effects.

DRGLIM-M2 Tablet is prescribed when diet, exercise, or single-drug therapy is not sufficient to maintain proper glycemic control. Regular use under medical supervision helps prevent long-term diabetes-related complications such as nerve damage, kidney problems, and cardiovascular issues.

⭐ Key Benefits

Effective control of Type 2 Diabetes Mellitus

Controls fasting and post-meal blood sugar levels

Improves insulin secretion and sensitivity

Prolonged-release formula for sustained action

Helps reduce risk of diabetic complications

✅ Composition

Glimepiride 2 mg

Metformin Hydrochloride Prolonged Release

🩺 Usage

Take DRGLIM-M2 Tablet once daily with meals or as directed by your doctor. Swallow the tablet whole; do not crush or chew. Regular blood sugar monitoring is advised.

⚠️ Precautions

Not for Type 1 Diabetes or diabetic ketoacidosis

Use cautiously in kidney or liver disease

Avoid alcohol consumption

Skipping meals may cause low blood sugar

Use during pregnancy or breastfeeding only on doctor’s advice

📦 Delivery Information

✔️ Fast delivery across India

✔️ Secure and tamper-proof packaging

🔄 Return Policy

✔️ Return accepted only if a wrong product is delivered

❌ No return if opened, used, or ordered incorrectly